- Home
- EW vs CTVA Comparison
EW vs CTVA Comparison
Compare EW & CTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EW | CTVA |
|---|---|---|
| Founded | 1958 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.5B | 44.7B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EW | CTVA |
|---|---|---|
| Price | $86.99 | $67.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 17 |
| Target Price | ★ $95.83 | $77.81 |
| AVG Volume (30 Days) | 3.0M | ★ 3.6M |
| Earning Date | 02-10-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | N/A | ★ 139.00 |
| EPS | 2.33 | ★ 2.35 |
| Revenue | $5,883,800,000.00 | ★ $17,469,000,000.00 |
| Revenue This Year | $14.29 | $6.91 |
| Revenue Next Year | $9.68 | $3.51 |
| P/E Ratio | $37.28 | ★ $28.72 |
| Revenue Growth | ★ 10.60 | 5.00 |
| 52 Week Low | $65.94 | $53.40 |
| 52 Week High | $87.89 | $77.41 |
Technical Indicators
Market Signals| Indicator | EW | CTVA |
|---|---|---|
| Relative Strength Index (RSI) | 60.64 | 60.79 |
| Support Level | $85.79 | $66.15 |
| Resistance Level | $86.98 | $67.63 |
| Average True Range (ATR) | 1.47 | 0.99 |
| MACD | 0.12 | 0.12 |
| Stochastic Oscillator | 90.52 | 99.15 |
Price Performance
Historical ComparisonAbout EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.